Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price shot up 4.8% on Thursday . The company traded as high as GBX 11 and last traded at GBX 11. Approximately 81,049 shares traded hands during trading, a decline of 66% from the average daily volume of 238,041 shares. The stock had previously closed at GBX 10.50.
Abingdon Health Stock Performance
The stock’s 50-day moving average price is GBX 10.46 and its 200-day moving average price is GBX 10.13. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The company has a market capitalization of £25.96 million, a P/E ratio of -12.68 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Recommended Stories
- Five stocks we like better than Abingdon Health
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
- MarketBeat Week in Review – 09/14 – 09/18
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
